Physician profile
Jacob Reznik
NPI 1528104999
$41,024.33
in general payments reported to CMS, 2019-2025
19 companies · $1,108 in 2025
The $1,108 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,290 · 2020: $7,081 · 2021: $2,925 · 2022: $7,808 · 2023: $6,771 · 2024: $14K · 2025: $1,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,325 · Food and Beverage: $2,569 · Entertainment: $25.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,325.00 |
| Food and Beverage | $2,569.29 |
| Entertainment | $25.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12,090.93 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $8,906.80 | 2019-2024 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Alcon Vision LLC | $6,892.14 | 2020-2025 | Hydrus Microstent, Argos, Clareon Panoptix Pro |
| New World Medical,INC. | $5,903.30 | 2019-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Via360 |
| Glaukos Corporation | $4,659.74 | 2019-2025 | Idosetr, Idose, Istent Infinite |
| Allergan, INC. | $791.95 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $418.95 | 2021 | |
| Amgen INC. | $258.48 | 2025 | Tepezza |
| Ivantis, INC | $181.30 | 2019 | |
| Bausch & Lomb Americas INC. | $172.93 | 2023 | Vyzulta, Miebo |
| Rxsight INC | $164.99 | 2022 | |
| Aerie Pharmaceuticals, INC. | $139.73 | 2019-2021 | |
| Oyster Point Pharma, INC. | $138.67 | 2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $119.87 | 2025 | Xdemvy |
| Nova Eye, INC. | $67.78 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $46.60 | 2025 | Iyuzeh |
| Optos, INC. | $25.98 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.53 | 2020 | |
| Sight Sciences, INC. | $19.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Reznik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.